Evaluation of clinical and genetic indicators for the early response to intravitreal ranibizumab in exudative age-related macular degeneration. [electronic resource]
- Pharmacogenomics Apr 2014
- 833-43 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1744-8042
10.2217/pgs.14.51 doi
Aged Antibodies, Monoclonal, Humanized--therapeutic use Asian People--genetics Complement Factor H--genetics Female Humans Intravitreal Injections--methods Macular Degeneration--drug therapy Male Polymorphism, Single Nucleotide--genetics Proteins--genetics Ranibizumab Retina--drug effects Retrospective Studies